Company intelligence / Profile preview
Zuvius Lifesciences
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
Overview
Zuvius Lifesciences manufactures and markets one of the world’s widest ranges of anti-cancer drugs, with over 130–200+ products spanning chemotherapeutics, supportive therapies, and nutraceuticals. The company has received national and international awards for its contributions to affordable oncology solutions. Its products adhere to international quality standards such as WHO-GMP and EU-GMP certifications. No specific clinical trial results are published; the focus appears to be on generic/specialty formulations rather than novel drug discovery.
- Therapeutic areas
- Oncology
- Modalities
- Small molecules (chemotherapeutic agents)Nutraceuticals and phytochemicalsSupportive care medicines for oncology
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Zuvius Lifesciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zuvius Lifesciences.